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Abstract. 
 
Skin wound healing depends on cell migra-
tion and extracellular matrix remodeling. Both pro-
cesses, which are necessary for reepithelization and res-
toration of the underlying connective tissue, are 
believed to involve the action of extracellular protein-
ases. We screened cDNA libraries and we found that 
six matrix metalloproteinase genes were highly ex-
pressed during rat skin wound healing. They were 
namely those of stromelysin 1, stromelysin 3, collage-
nase 3, gelatinase A (GelA), gelatinase B, and mem-
brane type-1 matrix metalloproteinase (MT1-MMP). 
 
The expression kinetics of these 
 
MMP
 
 genes, the tissue 
distribution of their transcripts, the results of cotrans-
fection experiments in COS-1 cells, and zymographic 
analyses performed using microdissected rat wound tis-
sues support the possibility that during cutaneous 
wound healing pro-GelA and pro-gelatinase B are acti-
vated by MT1-MMP and stromelysin 1, respectively. 
Since MT1-MMP has been demonstrated to be a mem-
brane-associated protein (Sato, H., T. Takino, Y. 
Okada, J. Cao, A. Shinagawa, E. Yamamoto, and M. 
Seiki. 1994. 
 
Nature (Lond.).
 
 370: 61–65), our finding 
that 
 
GelA
 
 and 
 
MT1-MMP
 
 transcripts were expressed 
in stromal cells exhibiting a similar tissue distribution 
suggests that MT1-MMP activates pro-GelA at the 
stromal cell surface. This possibility is further sup-
ported by our observation that the processing of pro-
GelA to its mature form correlated to the detection of 
MT1-MMP in cell membranes of rat fibroblasts ex-
pressing the 
 
MT1-MMP
 
 and 
 
GelA
 
 genes. These obser-
vations, together with the detection of high levels of the 
mature GelA form in the granulation tissue but not in 
the regenerating epidermis, suggest that MT1-MMP 
and GelA contribute to the restoration of connective 
tissue during rat skin wound healing.
 
S
 
kin
 
 wound healing is a complex process characterized
by reepithelization and restoration of the underly-
ing connective tissue. During this process, kerati-
nocytes, endothelial cells, fibroblasts, and inflammatory
cells proliferate and/or migrate to the site of injury, inter-
acting with each other and with extracellular matrices
(ECMs)
 
1
 
 (Gailit and Clark, 1994). 
The migration of cells and the remodeling of tissues dur-
ing wound healing require the controlled degradation of
the ECM and the activation or release of growth factors
(Vassalli and Saurat, 1996). These processes are achieved
by extracellular proteases, particularly those belonging to
the serine protease and matrix metalloproteinase (MMP)
families. It has been demonstrated that urokinase-deficient
mice develop nonhealing skin ulcerations (Carmeliet and
Collen, 1995) and that plasminogen-deficient mice have a
marked defect in the closure of skin wounds (Rømer et al.,
1996). However, the exact contribution of MMPs to wound
healing has not been well established yet. The expression
of gelatinase A (GelA) was localized in the connective tis-
sue and that of gelatinase B (GelB) in the migrating epi-
thelial sheet during human skin wound healing (Salo et al.,
1994). In healing human burn wounds, 
 
interstitial collagenase
 
(
 
Col1
 
) RNA has been detected in epithelial cells, hair folli-
cles, and eccrine sweat structures (Stricklin et al., 1993). Fur-
thermore, in vitro studies indicate that Col1 may play a role
in the formation of new blood vessels (Fisher et al., 1994).
 
Address all correspondence to Paul Basset, Institut de Génétique et de
Biologie Moléculaire et Cellulaire, Centre National de la Recherche Sci-
entifique/Institut National de la Santé et de la Recherche Médicale/Uni-
versité Louis Pasteur, BP 163, 67404 Illkirch Cedex, France. Tel.: 33 3 88
65 34 25. Fax: 33 3 88 65 32 01. E-Mail: basset@igbmc.u-strasbg.fr
The current address of A. Okada is the Department of Cancer Cell Re-
search, Institute of Medical Science, University of Tokyo, Tokyo 108, Japan.
 
1.
 
 Abbreviations used in this paper
 
: Col1, interstitial collagenase; Col2,
neutrophil collagenase; Col3, collagenase 3; ECM, extracellular matrix;
GelA and GelB, gelatinase A and B; MMP, matrix metalloproteinase;
MT1-MMP, MT2-MMP, MT3-MMP, and MT4-MMP, membrane-type-1,
-2, -3, and -4 MMP; ST1, ST2, and ST3, stromelysin 1, 2, and 3; TIMP1, 2,
and 3, tissue inhibitor of metalloproteinase type-1, -2, and -3.
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When the present study was initiated, ten human MMPs
were known (Col1-3, stromelysin1-3 [ST1-3], GelA, GelB,
matrilysin, and the macrophage metalloelastase; reviewed in
Birkedal-Hansen, 1995), while only four rat MMPs (ST1,
Matrisian et al., 1986
 
a
 
; ST2, Breathnach et al., 1987; Col3
[According to Knäuper et al. (1996), the rat collagenase
identified by Quinn et al. (1990) should be considered as
the rat counterpart of collagenase 3], Quinn et al., 1990;
GelA, Marti et al., 1993) had been identified. To gain insight
into the contribution of MMPs to wound healing, we de-
signed a two-step procedure for screening cDNA libraries,
which allowed the identification of MMPs expressed highly
during rat skin wound healing. We thus identified six rat
 
MMP
 
 cDNAs, including 
 
ST1
 
, 
 
ST3
 
, 
 
Col3
 
, 
 
GelA
 
, 
 
GelB
 
,
 
 
 
and
a novel member of the MMP family. The latter one was
found to exhibit a high level of homology with a human
 
MMP
 
 cloned by Sato et al. (1994), and now known as mem-
brane-type-1 MMP (MT1-MMP; Sato and Seiki, 1996).
MT1-MMP is the first member of a new MMP subgroup
characterized by its localization at the cell surface, where it
is anchored through a transmembrane domain located at
the COOH-terminal portion of the molecule. Three addi-
tional MT-MMPs (MT2-MMP, Will and Hinzmann, 1995;
MT3-MMP [Although the MT-MMP described by Takino
et al. (1995) was initially termed MT2-MMP, this MMP
should be now referred as MT3-MMP and that found by
Will and Hinzmann (1995) as MT2-MMP] Takino et al.,
1995; MT4-MMP, Puente et al., 1996) have so far been de-
scribed. While the function of MT4-MMP is still unknown,
the three other MT-MMPs have been shown to be cell sur-
face activators of pro-GelA. MT1-MMP was predomi-
nantly detected in malignant cells of lung and gastric carci-
nomas (Sato et al., 1994; Nomura et al., 1995; Tokuraku et al.,
1995). This has led to the proposition that MT1-MMP acti-
vates pro-gelA at the cancer cell surface (Sato and Seiki,
1996). However, 
 
MT1-MMP
 
 transcripts were predomi-
nantly detected in fibroblastic cells of colon, breast, and
head and neck carcinomas (Okada et al., 1995
 
a
 
; Heppner
et al., 1996). These observations suggest that pro-GelA ac-
tivation by MT1-MMP also occurs at the stromal cell surface,
which is supported by the specific expression of MT1-MMP
in microglial cells of brain tissues (Yamada et al., 1995). Fur-
thermore, 
 
MT1-MMP
 
 gene expression has been recently
demonstrated in mesenchymal cells of mouse embryos (Ki-
noh et al., 1996), indicating that this MMP could contrib-
ute to pro-GelA activation in physiological conditions. 
In the present study, we show that 
 
MT1-MMP
 
 and 
 
GelA
 
RNAs are both expressed in stromal cells of rat skin
wounds, and that high levels of the mature GelA form are
detected in the wound stroma, but not in the regenerating
epithelium. These findings suggest that during rat skin
wound healing, GelA is activated at the stromal cell sur-
face by MT1-MMP and contributes to the remodeling
processes implicated in the restoration of the connective
tissue.
 
Materials and Methods
 
Animals 
 
Pathogen- and virus-free 10-wk-old female Wistar rats were obtained
from IFFA-CREDO (L’Arbresle, France). Animals were maintained un-
der the guidelines of the Institut de Génétique et de Biologie Moléculaire
 
et Cellulaire (IGBMC). Rats were fed with “D 04” (Usine Alimentation
Rationnelle, Epinay-sur-Orge, France) and tap water ad libitum. Rat dor-
sal skin was shaved and cleaned with isopropyl alcohol under anesthesia,
and the skin was linearly incised (3-cm long) up to the level of the subcuta-
neous adipose tissue. Incisions were made on either side of the midline us-
ing a #10 sterile surgical scalpel. A sterile dressing was then placed circum-
ferentially around the trunk in order to protect against infection. On days
1, 3, 5, 7, 10, and 14 after wounding, the entire dorsal skin encompassing
healing wounds was excised. For RNA and protein extractions, wound tis-
sues were immediately frozen in liquid nitrogen. For RNA in situ hybrid-
ization and histopathological examination, the samples were embedded in
OCT compound (Miles, Elkhart, IN), and frozen in liquid nitrogen. Ade-
quate sampling was ensured by obtaining wound specimen from at least
three separate animals for each time point.
 
Cell Lines
 
COS-1 cells (Amer. Type Culture Collection, Rockville, MD), and RAT1
and FR3T3 rat fibroblasts (Matrisian et al., 1985) were grown and main-
tained in DMEM supplemented with 5% or 10% FCS, or 10% calf serum,
respectively. Con A (Sigma Chem. Co., St. Louis, MO) treatment of rat fi-
broblasts in culture was carried out in serum-free DMEM supplemented
with 50 
 
m
 
g/ml Con A for 24 h (Overall and Sodek, 1990). After treatment,
conditioned media and cells were harvested for protein analysis and RNA
extraction.
 
RNA Extraction
 
Tissues were homogenized in 4 M guanidinium thiocyanate (Merck, Darm-
stadt, Germany). Total RNA was purified by ultracentrifugation (SW60
rotor, Beckman Instrs., Fullerton, CA, 35,000 rpm) through a 2.5-ml cush-
ion of 5.7 M cesium chloride. Cells in culture were washed with PBS, and
RNA was extracted using the single-step method of Chomczynski and
Sacchi (1987).
 
Construction of a Rat Skin Wound cDNA Library and 
Cloning of cDNAs Encoding MT1-MMP
 
Poly(A)
 
1
 
RNA from rat skin wounds was purified using the Pharmacia pu-
rification kit (Uppsala, Sweden). The RNA thus isolated was used to con-
struct a cDNA library with the Uni-ZAP™XR Vector kit (Stratagene, La
Jolla, CA). This library was screened with size-selected (
 
z
 
350–550 bp) RT-
PCR products. For the RT-PCR experiments, poly(A)
 
1
 
RNA from rat
skin wounds was reverse-transcribed using an oligo (dT) primer, and the
resulting cDNA was amplified using a set of degenerate primers corre-
sponding to the cysteine-switch and zinc-binding domains of rat MMPs
(5'-C(CT)N(AC)GNTGTGGN(AG)(AT)NCCNGA, and 5
 
9
 
-(CT)C(AG)
A(AG)(CT)TC (AG)TGNGC(AT)GC(AC)AC, respectively). Additional
screening was conducted using cDNA probes (see Results) encoding rat
GelA (nucleotides 482-2306; accession number No. U65656), GelB (nucle-
otides 517-2392), ST1 (nucleotides 418-1771), ST3 (nucleotides 644-1810),
and Col3 (nucleotides 1387-2606). The clones which were only recognized
by the RT-PCR probe, were plaque-purified and used for plasmid rescue.
After cross-hybridization experiments, all independent clones were se-
quenced from their 5
 
9
 
-terminus. The full nucleotide sequence of rat 
 
MT1-
MMP
 
 cDNA was determined on both strands as previously described
(Okada et al., 1995
 
a
 
). Nucleotide and amino acid sequences were analyzed
using the sequence analysis software of the Wisconsin program package. 
 
Cloning of cDNAs Encoding Rat TIMP2 and TIMP3
 
Rat 
 
tissue inhibitor of metalloproteinase type-2 
 
(
 
TIMP2
 
) (Santoro et al., 1994)
and 
 
TIMP3
 
 (Wu and Moses, 1996) cDNA fragments containing the com-
plete open reading frame sequence were obtained by PCR amplification
from a previously described skin wound library (Okada et al., 1994) and a
13.5-d placenta library in the
 
 
 
l
 
 
 
ZAPII vector, respectively. The PCR
products were cloned into the pBluescript vector and sequenced.
 
RNA Analyses
 
For Northern blot analysis, 10 
 
m
 
g of total RNA from rat tissues was elec-
trophoresed on formaldehyde-agarose (1%) gels and transferred to Hy-
bond-N membranes (Amersham, Buckinghamshire, UK), according to the
supplier’s instructions. Hybridizations were carried out with 
 
32
 
P-labeled
cDNA probes in 50% formamide at 42
 
8
 
C. The cDNA probes used for
these hybridizations were identical to those used for the differential 
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screening of the skin wound cDNA library. An additional probe used for
hybridization was rat 
 
MT1-MMP 
 
cDNA (nucleotides 911-2410). 
For in situ hybridization, tissue sections from rat normal skin and skin
wounds were collected as described above. Sections were cut perpendicu-
larly to the cutaneous incision. 
 
35
 
S-labeled RNA sense and antisense
probes were synthesized from DNA templates identical to those used for
Northern blot analyses, using either the T3 or T7 polymerase. Probe
length was reduced to an average size of 150 nucleotides by limited alka-
line hydrolysis before hybridization as previously described (Okada et al.,
1995
 
a
 
). Frozen sections were fixed with 4% paraformaldehyde, dehy-
drated, and hybridized with 
 
35
 
S-labeled RNA probes. After washing, au-
toradiography was performed using NTB2 emulsion (Kodak, Rochester,
NY). Slides were then developed and counterstained with toluidine blue.
 
Construction of Expression Plasmids for Rat MMPs 
and TIMPs 
 
To express rat MT1-MMP in 
 
E. coli
 
, a cDNA fragment encoding the puta-
tive catalytic domain and the hemopexin-like domain (amino acids 112-
508) was inserted into the pET15b vector containing an NH
 
2
 
-terminal
6-histidine tag (Novagen, Madison, WI). For expression in COS-1 cells,
cDNA fragments containing the complete open reading frame sequence
of rat MT1-MMP, GelA, GelB, ST1, ST3, TIMP1 (Okada et al., 1994),
TIMP2, and TIMP3, were inserted into the pTL1 expression vector as pre-
viously described (Okada et al., 1995
 
b
 
). The resulting plasmids,
pET15bMT1-MMP (MT1-MMP, amino acids 112-508), pTL1MT1-MMP
(pro-MT1-MMP), pTL1GelA (pro-GelA), pTL1GelB (pro-GelB),
pTL1ST1 (pro-ST1), pTL1ST3 (pro-ST3), pTL1TIMP1 (TIMP1),
pTL1TIMP2 (TIMP2), and pTL1TIMP3 (TIMP3) were verified by restric-
tion enzyme digestion and DNA sequencing. 
 
Transient Transfection into COS-1 Cells 
 
pTL1 expression plasmids for rat MMPs and TIMPs,
 
 
 
and the control
pTL1 vector alone were transiently transfected into COS-1 cells using the
calcium phosphate procedure. 5 
 
3 
 
10
 
5 
 
COS-1 cells per 10-cm diameter cul-
ture dish were grown in DMEM supplemented with 5% FCS for 16 h, and
transfected with 3 
 
m
 
g of each expression plasmid and 12 
 
m
 
g of carrier
DNA (pBluescript vector) in fresh culture medium. After a 1-d incuba-
tion, cells were washed with DMEM and incubated in 3 ml of serum-free
DMEM for another day.
 
Gelatin Zymography
 
Zymography was performed as previously described (Okada et al., 1995
 
b
 
),
using conditioned media or rat tissues. 20 
 
m
 
l of each conditioned medium
was mixed with a same volume of Laemmli’s 2
 
3
 
 SDS sample buffer in the
absence of a reducing agent, and incubated for 30 min at 22
 
8
 
C. The sam-
ples were electrophoresed on 8%-polyacrylamide gels containing 0.2%
gelatin. After electrophoresis, gels were soaked in 50 mM Tris-HCl (pH
7.6) containing 2.5% Triton X-100 for 30 min, and incubated with 50 mM
Tris-HCl (pH 7.6) containing 150 mM NaCl, 10 mM CaCl
 
2
 
,
 
 and 0.02%
Brij-35, at 37
 
8
 
C for 16 h. Gels were subsequently stained with 0.5% Coo-
massie brilliant blue R-250. Protein molecular standards were purchased
from Bio-Rad (Hercules, CA).
Normal rat skin epidermis and dermis, and proliferative epidermis or
granulation tissue from rat skin wounds were carefully microdissected un-
der a light microscope from 30-
 
m
 
m thick frozen sections. After microdis-
section, individual samples were suspended in Laemmli’s 2
 
3
 
 SDS sample
buffer (40 
 
m
 
l/mg of fresh tissue). After a 30-min incubation at 22
 
8
 
C, the
extracted proteins were analyzed by gelatin zymography as described
above. 
 
Western Blot Analysis 
 
Anti-rat MT1-MMP mAb (1MMP-1C1) was obtained by immunizing Balb/c
mice with recombinant rat MT1-MMP (amino acids 112-508) purified from
 
E. coli
 
 inclusion bodies. The antigen was purified by Ni
 
2
 
1
 
-NTA-Agarose
(Qiagen Inc., Chatsworth, CA) chromatography according to the manu-
facturer’s instruction. The specificity of mAb 1MMP-1C1 for MT1-MMP
was demonstrated by immunocytochemical analysis of COS-1 cells trans-
fected with cDNAs for 
 
MT1-MMP
 
, 
 
MT2-MMP
 
 (Will and Hinzmann,
1995), or 
 
MT3-MMP
 
 (Takino et al., 1995).
Subconfluent transfected COS-1 cells, and RAT1 and FR3T3 rat fibro-
blasts incubated with serum-free DMEM in the absence or presence of 50
 
m
 
g/ml Con A for 24 h, were scraped and lysed in PBS containing 1% NP-
40 and 5 mM EDTA (100 
 
m
 
l/ 10-cm diam culture plate). After centrifuga-
tion at 4,000 
 
g
 
 for 15 min, supernatants corresponding to crude cell mem-
brane extracts were collected and used for Western blot analysis (Okada
et al., 1997). Proteins were separated by electrophoresis performed on
10%-polyacrylamide gels under reducing conditions. The proteins were
then electrophoretically transferred to a nylon membrane (Immobilon-P,
Millipore, Bedford, MA). After treatment with a blocking solution, the
nylon membrane was incubated with anti-rat MT1-MMP mouse mAb
1MMP-1C1, diluted 1/1,000 in PBS containing 2% BSA. The nylon mem-
brane was washed and incubated with peroxidase-conjugated goat anti–
mouse IgG antibody (Jackson ImmunoResearch Laboratory, West
Grove, PA). After washing in PBS containing 0.05% Tween-20, proteins
were detected using a chemiluminescence procedure (Renaissance, Du-
Pont, Boston, MA).
 
Results
 
Cloning of Rat MT1-MMP from a Skin Wound
cDNA Library
 
To investigate the contribution of MMPs to skin wound
healing, we devised a two-step procedure to identify
 
 MMP
 
genes expressed during this process. As a first approach,
screening of a 5-d rat skin wound library constructed in the
 
l
 
gt10 vector (Okada et al., 1994) with six human 
 
MMP
 
cDNA probes (
 
ST2, ST3, Col1, GelA, GelB
 
, and 
 
matrilysin
 
),
led to the identification of four rat 
 
MMP
 
 cDNAs (
 
ST1,
ST3, GelA
 
, and 
 
GelB
 
) (Okada et al., 1995
 
b
 
, 1997, and
Okada, A., unpublished results). However, 
 
ST2
 
, 
 
matril-
ysin
 
, and the rat homologue of human 
 
Col1
 
 were not
found in the library. A nearly full-length cDNA for rat
Col3 (nucleotides 145-2583) was obtained by screening the
library with a partial rat 
 
Col3
 
 cDNA fragment (nucleotides
865-1262, Quinn et al., 1990).
The next step was to determine whether other MMPs
were expressed during rat skin wound healing. We con-
structed a second cDNA library in the Uni-ZAP™XR
vector (Stratagene, La Jolla, CA) using RNA prepared
from healing wounds on days 3 and 5 after cutaneous inci-
sion, which corresponded to the period of concomitant ex-
pression of the 
 
MMP
 
 genes already identified (Fig. 1 
 
A
 
).
For screening this second library, a probe was designed in
such a way that any known or novel members of the MMP
family would be identified. We amplified 3- and 5-d rat
skin wound RNA by RT-PCR, using a set of degenerate
primers derived from nucleotide sequences corresponding
to the highly conserved cysteine-switch and zinc-binding
domains of the six rat MMPs known at that time (ST3,
GelA, GelB, ST1, ST2, and Col3) (Fig. 2).
Sixty thousand plaques of the ZAP library were screened
with the RT-PCR probe. After dehybridization, the same
membranes were hybridized with the five rat 
 
MMP
 
 cDNA
probes (
 
ST3
 
, 
 
GelA
 
, 
 
GelB
 
, 
 
ST1
 
, and 
 
Col3
 
) previously iso-
lated. Among the clones that were detected selectively by
the RT-PCR probe and not by the
 
 MMP
 
 cDNA probes,
we identified 10 cDNAs which had been previously de-
scribed that did not belong to the MMP family, and 11
novel cDNA sequences (data not shown). One of them
was found to correspond to a putative novel member of
the MMP family, and by sequence homology we proposed
that it represented the rat homologue of human MT1-
MMP (Sato et al., 1994; Okada et al., 1995
 
a
 
). Although
three other human MMPs containing a transmembrane
domain have since been described (Will and Hinzmann,
1995; Takino et al., 1995; Puente et al., 1996), the rat MMP 
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that we have identified exhibits the highest sequence ho-
mology with human MT1-MMP until now (data not shown).
 
Expression of MMP RNAs during Skin Wound Healing
 
MT1-MMP
 
 RNA was found to be expressed in most nor-
mal adult rat tissues (data not shown). However, higher
levels of 
 
MT1-MMP
 
 RNA were detected during rat skin
wound healing. 
 
MT1-MMP
 
 RNA expression was maximal
on day 5 after cutaneous incision (Fig. 1 
 
A
 
). This corre-
sponded to a period of intense stromal activity, filling of
granulation tissue in the incisional space, maximal neovas-
cularization, and when collagen fibers were present at the
incision margins where the scar tissue was being formed.
The expression kinetics of 
 
GelA
 
 RNA was identical to that
of 
 
MT1-MMP
 
 (Fig. 1 
 
A
 
). However, 
 
ST3
 
 RNA was highly
expressed only on day 5 and reached a peak on day 7. The
maximal expression of 
 
ST1
 
 RNA was detected on day 1 af-
ter cutaneous incision. 
 
GelB
 
 and 
 
Col3 RNAs were also
highly expressed on day 1, and maintained high expression
levels until day 5. 
We then examined MMP transcript distribution by in
situ hybridization on normal skin sections and skin wound
sections from days 1–14 after cutaneous incision. Each
wound was examined at its extreme and median portions.
The results of analyses performed on days 3 and 5 are pre-
sented in Fig. 3. On day 3, various stages of granulation tis-
sue and immature capillary lumens were observed, to-
gether with spurs of epithelial cells migrating from both
edges of wounds beneath the surface scab (Fig. 3 A and
data not shown). MT1-MMP transcripts were detected in
cells of the granulation tissue and those of the superficial
dermis juxtaposed to the proliferative epithelial cell layer
(Fig. 3 B). The transcripts were also observed in stromal
cells surrounding hair follicles and especially in the dermal
papilla. Most cells expressing MT1-MMP transcripts were
of the fibroblastic type, thus likely corresponding to fibro-
blasts or myofibroblasts. However, some cells were round
or oval, suggesting that other types of stromal cells, includ-
ing endothelial cells or macrophages, may also express the
MT1-MMP gene. While it is clear that additional studies
are required to better define the precise nature of these
stromal cells, MT1-MMP transcripts could not be detected
in any epithelial cell. The localization of GelA transcripts
was similar to that observed for MT1-MMP, although the
expression levels were higher for GelA than for MT1-
MMP (Fig. 3 C). ST3 transcripts were undetectable, ex-
cept in a few stromal cells surrounding hair follicles (Fig.
3 D). ST1 transcripts were detected in some proliferative
epithelial basal cells, and in a few stromal cells juxtaposed
to the proliferative epithelial layer (Fig. 3 E). GelB and
Col3 RNAs were highly expressed in the epithelial basal cell
layer, but not in the dermis (Fig. 3, F and G). On day 5,
though granulation tissue was still observed in the median
portion of incision (data not shown), reepithelization had
been completed at the wound extremities, where thick-
ened epidermis, scar tissue and tissue contraction were ob-
served (Fig. 3 H). MT1-MMP, GelA, and ST3 transcripts
Figure 1. Northern blot analysis of MMP and TIMP RNAs during rat skin wound healing. Total RNA (10 mg) from normal skin (lanes
1) and skin wounds on days 1, 3, 5, 7, 10, and 14 after cutaneous incision (lanes 2–7), were electrophoresed, transferred to nylon mem-
branes, and hybridized with 32P-labeled cDNA probes for rat MT1-MMP, GelA, ST3, ST1, GelB, Col3 (A); TIMP1, TIMP2, TIMP3 (B).
Blots were reprobed with the 36B4 cDNA used as a loading control (Masiakowski et al., 1982).Okada et al. Stromal Activation of Pro-Gelatinase A by MT1-MMP 71
were detected in cells of the scar tissue, below the thick-
ened epithelial cell layer (Fig. 3, I–K). The distribution of
MT1-MMP transcripts (Fig. 3 I) was more narrow than
that of GelA (Fig. 3 J), but broader than that of ST3 (Fig.
3 K). MT1-MMP, GelA, and ST3 transcripts were not de-
tected in epithelial cells. ST1 transcripts were not detected
(Fig. 3 L). GelB and Col3 transcripts were intensely ex-
pressed in some basal cells of the thickened epidermis, and
in some cells of the hair follicle sheath (Fig. 3, M and N).
MMP Interactions during Skin Wound Healing
Expression vectors encoding rat MT1-MMP, GelA, GelB,
ST1, and ST3, were transiently transfected into COS-1
cells, which do not produce any detectable levels of these
MMPs endogenously (Okada et al., 1995b, 1997, and  data
not shown). The expression plasmids were transfected in
pairs into COS-1 cells. Conditioned media were analyzed
by gelatin zymography for GelA and GelB production. As
shown in Fig. 4 A, pro-GelA was selectively activated by
MT1-MMP, and pro-GelB by ST1 only. Other combina-
tions which could not be analyzed by gelatin zymography,
were investigated by Western blot analyses and immuno-
precipitation, using specific antibodies against ST1 (Matri-
sian et al., 1986b), ST3 (mAb 5ST-4C10, Santavicca et al.,
1995), and MT1-MMP (mAb 1MMP-1C1). None of the
other pairs led to activation of the MMP proform (data not
shown). Furthermore, MT1-MMP was found exclusively
in crude cell membrane extracts and could not be detected
in conditioned media (data not shown).
The possibility that MT1-MMP interacts with GelA, and
ST1 with GelB, respectively, during rat skin wound healing,
appears consistent both with the expression kinetics of their
RNAs (Fig. 1 A) and their expression patterns in wound
Figure 2. Amino acid sequence alignments of rat MMPs. Amino acids are represented using the one-letter code. The predicted amino
acid sequences of MT1-MMP, ST3, GelA, GelB, and ST1 were derived from cDNAs cloned from two distinct rat skin wound libraries
(Okada et al., 1994, and the present study). One amino acid residue of ST1 (isoleucine 189) differs from the corresponding residue (threo-
nine) in the sequence reported by Matrisian et al. (1985). The sequences of ST2, Col3, and matrilysin were obtained from the PIR-protein
data bank. These sequences were aligned using the CLUSTAL program of the Wisconsin program package. Identical amino acid residues
in all MMPs are indicated by asterisks below the sequences. The cysteine-switch region (P-/LRCGV/NPD), and the zinc-binding domain
(XVAXHXHEL/FGHXL/MGLXHS/T) are in the boxed regions. The two regions selected for designing the degenerated oligoprimers
used for RT-PCR amplification are indicated by arrows above the sequences. The putative transmembrane segment (amino acid 539-
563) of rat MT1-MMP is overlined. The Journal of Cell Biology, Volume 137, 1997 72
Figure 3. In situ hybridization of rat MMP RNAs in cutaneous wounds. Serial frozen sections of rat skin wounds on day 3 (A–G), or day
5 (H–N) after cutaneous incision, were hybridized with 35S-labeled antisense RNA probes derived from cDNA templates for rat MT1-
MMP (B and I), GelA (C and J), ST3 (D and K), ST1 (E and L), GelB (F and M), Col3 (G and N), or stained with hematoxylin and eosin
(A and H). Note that the hair follicle which is observed on sections B and C, is only partially visible on  A (arrows). In D and E, arrows
indicate transcripts expressed in stromal cells surrounding a hair follicle and juxtaposed to the proliferative epithelial cell layer, respec-
tively. No signal above background could be detected with the corresponding 35S-labeled sense RNA probes (data not shown). gt, gran-
ulation tissue; e, epithelial layer; hf, hair follicle; s, scar tissue. Bar, 100 mm.Okada et al. Stromal Activation of Pro-Gelatinase A by MT1-MMP 73
tissues (Fig. 3). Thus, MT1-MMP and GelA transcripts were
detected in stromal cells exhibiting a similar tissue distri-
bution (Fig. 3, B, C, I, and J). In the case of ST1 and GelB,
the expression patterns of their transcripts were not super-
imposable on day 5 after cutaneous incision (Fig. 3, L and
M). However, ST1 and GelB transcripts were co-expressed in
the proliferative epithelial basal cell layer on day 1 (data
not shown) and to some extent on day 3 (Fig. 3, E and F),
when the mature form of GelB was detected in wound tis-
sues (see below). We also note that the GelB and Col3
genes exhibited comparable expression kinetics (Fig. 1 A)
and distribution of transcripts in tissues (Fig. 3, F, G, M,
and N), suggesting that GelB and Col3 could also interact
during rat skin wound healing. However, we could not fur-
ther evaluate this possibility in the present study, since we
could not obtain any full-length rat Col3 cDNA for pro-
tein expression.
Pro-GelA Activation by MT1-MMP Is Regulated by 
TIMP2 and TIMP3
Activity of mature MMP forms and activation of proforms
are regulated by their physiological inhibitors, the TIMPs
(Stetler-Stevenson et al., 1996). In particular, TIMP2 has
been shown to be both a more efficient inhibitor than
TIMP1 in pro-GelA activation (Atkinson et al., 1995) and
an active agent in promoting pro-GelA binding to MT1-
MMP (Strongin et al., 1995). The effect of TIMP3 on the
activation of pro-GelA has not been reported yet. As
shown in Fig. 1 B, TIMP1 RNA was not expressed in nor-
mal skin, while TIMP2 and TIMP3 RNAs were weakly ex-
pressed. The induction kinetics of TIMP1 RNA after cuta-
neous incision was comparable to that of ST1, while that of
TIMP2 was identical to that of MT1-MMP and GelA (com-
pare Fig. 1, A and B). However, the induction kinetics of
TIMP3 RNA was different from that of the other TIMPs
and the six MMPs examined. TIMP3 kinetics exhibited a
biphasic pattern, with the highest RNA levels on day 1 af-
ter cutaneous incision, which corresponds to the onset of
epithelial and mesenchymal cell migrations, and on day 10,
when cell migration terminates.
To test the influence of TIMPs on pro-GelA activation
by MT1-MMP, we performed triple transfection experi-
ments in COS-1 cells. Different TIMPs and pro-GelA/
MT1-MMP expression plasmids were used for these triple
transfections. Pro-GelA activation by MT1-MMP was not
affected by the presence of TIMP1 (Fig. 4 B, lane 3) and
only partially prevented by TIMP2 (Fig. 4 B, lane 4). How-
ever, TIMP3 was found to completely inhibit pro-GelA ac-
tivation by MT1-MMP (Fig. 4 B, lane 5). In contrast to the
observations made for GelA and MT1-MMP, pro-GelB
activation by ST1 was similarly prevented by all the three
TIMPs (Fig. 4 B, lanes 7–10). These observations strongly
suggest that TIMP3 may be a physiological inhibitor of pro-
GelA activation by MT1-MMP.
Pro-GelA Is Activated by MT1-MMP-Expressing
Rat Fibroblasts
During rat skin wound healing, MT1-MMP and GelA tran-
scripts were specifically found in wound stromal cells (Fig.
3, B, C, I, and J). This finding prompted us to examine
MT1-MMP and GelA gene expression in two different rat
fibroblast cell lines, RAT1 and FR3T3. Both cell lines were
found to express high levels of MT1-MMP and GelA tran-
scripts (Fig. 5 A, lanes 1 and 3). However, the MT1-MMP
protein could not be detected either in crude cell mem-
brane extracts or in cytosolic fractions by Western blot
analysis (Fig. 5 B, lanes 1 and 3, and data not shown). Con-
sistently, media conditioned by these cells contained mainly
pro-GelA, as shown by gelatin zymography (Fig. 5 C,
lanes  3  and  5). Since pro-GelA activation has been demon-
strated to be induced by Con A treatment in human fibro-
blasts (Overall and Sodek, 1990), we then examined
whether treatment with con A of these rat fibroblasts was
associated with pro-GelA activation. Although both cell
lines stimulated by Con A showed only a weak increase in
MT1-MMP and GelA transcript levels (Fig. 5 A, lanes 2
and 4), the MT1-MMP protein could now be easily de-
tected by Western blot analysis of crude cell membrane
fractions prepared from the Con A–treated cells (Fig. 5 B,
lanes 2 and 4). Furthermore, as shown by gelatin zymogra-
phy, the mature form of GelA was found to be the major
GelA species represented in media conditioned by Con
A–treated cells (Fig. 5 C, lanes 4 and 6).
Detection of High Levels of GelA and GelB Activities in 
the Granulation Tissue
To directly evaluate pro-GelA activation during rat skin
wound healing, we analyzed microdissected tissue samples
from frozen sections by gelatin zymography. These sam-
ples were collected at different times after cutaneous inci-
sion. In wound tissues containing both the stroma and epi-
thelium, protein species corresponding to pro-GelA/GelA
were detected from days 1–14, and pro-GelB or pro-GelB/
GelB were detected from days 1–7 (Fig. 6 A). The level of
pro-GelA was maximal on day 5, when the granulation tis-
sue was most active, and pro-GelB expression was ele-
vated all through from days 1–5. However, the mature
form of GelB was only detected on days 1 and 3, while the
mature form of GelA was observed, along with its corre-
sponding pro-form, in all the tissue samples examined
(Fig. 6). When the granulation tissue and the proliferative
epithelial cell layer from healing wounds on days 3 and 5
were analyzed separately, pro-GelA/GelA was almost
exclusively detected in the granulation tissue (Fig. 6 B). Pro-
GelB/GelB was also predominantly detected in the granu-
lation tissue, with only low levels associated with the pro-
liferative epithelial cell layer. These observations indicate
that the wound stroma is the predominant site of action
for both GelA and GelB during rat skin wound healing.
Discussion
MMP Gene Expression during Rat Skin Wound Healing
In the present study, we found that six MMP (ST1, ST3,
GelA, GelB, Col3, MT1-MMP) genes were expressed dur-
ing rat skin wound healing. However, we could not detect
rat ST2 and matrilysin cDNAs, nor the rat homologue of
human Col1 cDNA in the skin wound cDNA libraries
used for our screening. Furthermore, we could detect nei-
ther MT2-MMP nor MT3-MMP RNA in wound tissues by
Northern blot analysis (Okada, A., unpublished results).The Journal of Cell Biology, Volume 137, 1997 74
Among the six MMP genes expressed during rat skin
wound healing, ST1, GelB, and Col3 were mainly ex-
pressed between days 1 and 5 after cutaneous incision,
while the three others, MT1-MMP, GelA, and ST3, contin-
ued to be expressed at high levels at least until day 7. In-
terestingly, the transcripts corresponding to the early
genes were found predominantly in migrating epithelial cells
while those corresponding to the late genes were specifically
detected in wound stromal cells. However, MT1-MMP
and GelA transcripts were both found in granulation and
scar tissues, while ST3 expression was not detected in
granulation tissue.
Pro-GelB Activation by ST1
Ogata et al. (1992) have demonstrated that human pro-
GelB was processed to its mature form by human ST1
when both enzymes were incubated together in vitro. In
agreement with this observation, we found that rat pro-
GelB was processed to its mature form by rat ST1 when
the two cDNAs corresponding to GelB and ST1 were
transiently transfected into COS-1 cells. The expression
kinetics of GelB and ST1 genes, the tissue distribution of
cells expressing their transcripts, and the detection of ma-
ture GelB protein in wound tissue from days 1 to 3 after
cutaneous incision all together support the possibility that
pro-GelB is activated by ST1 during rat skin wound heal-
ing. The most convincing argument is that while GelB
transcripts and protein were detected at similar high levels
from days 1 to 5 after cutaneous incision, the active form
of GelB was only detected from days 1 to 3, consistent
with maximal ST1 gene expression on day 1. Finally, we
Figure 4. Pro-GelA and pro-
GelB activation by MT1-
MMP and ST1, in the ab-
sence or presence of TIMPs.
(A) COS-1 cells were tran-
siently cotransfected with ex-
pression plasmids for MMPs
whose transcripts were found
to be expressed during rat skin
wound healing (Figs. 1 and
3), according to the following
combinations: pTLlGelA and
pTL1 (lane 1) or pTL1MT1-
MMP (lane 2) or pTL1ST1
(lane  3) or pTL1ST3 (lane 4)
or pTL1GelB (lane 5);
pTL1GelB and pTL1MT1-
MMP (lane 6) or pTL1ST1
(lane  7) or pTL1ST3 (lane 8)
or pTL1 (lane 9). (B) COS-1
cells were transiently cotrans-
fected with pTL1GelA and
pTL1 (lane 1), or pTL1GelA
and pTL1MT1-MMP (lanes
2–5), or pTL1GelB and pTL1
(lane  6), or pTL1GelB and
pTL1ST1 (lanes 7–10), in the
absence (lanes 1, 2, 6, and 7)
or presence of one of the
TIMP expression plasmids:
pTL1TIMP1 (lanes 3 and 8),
pTL1TIMP2 (lanes 4 and 9),
pTL1TIMP3 (lanes 5 and
10). In A and B, 20 ml of each
conditioned medium was an-
alyzed by gelatin zymography. Okada et al. Stromal Activation of Pro-Gelatinase A by MT1-MMP 75
observed that pro-GelB/GelB were predominantly de-
tected in wound stroma, although their transcripts were
predominantly expressed in the epithelial basal cell layer.
Taken together, these observations support the proposi-
tion of Salo et al. (1994) that GelB plays a role in epithelial
cell migration, assuming that the substrate for GelB is
found in the wound stroma immediately surrounding the
migrating epithelial cells.
Pro-GelA Activation by MT1-MMP
Our finding that pro-GelA was processed to its corre-
sponding mature form when rat MT1-MMP and GelA
cDNAs were transiently expressed in COS-1 cells, is con-
sistent with the previous observation of Sato et al. (1994)
made with the human enzymes. However, GelB, ST1, or
ST3 could not activate pro-GelA. The possibility that pro-
GelA activation by MT1-MMP also occurs during rat skin
wound healing is supported by some of our observations.
First, MT1-MMP and GelA transcripts were found to be
expressed by wound stromal cells exhibiting a similar tis-
sue distribution. Second, the expression kinetics after cu-
taneous incision were identical for both genes. Third, high
levels of the mature form of GelA were observed in the
wound stroma, particularly on day 5 after cutaneous inci-
sion when both the MT1-MMP and GelA RNAs attained
their highest expression levels. However, the ratios be-
tween the amounts of mature GelA and pro-GelA were
found to be similar in all the wound tissue samples exam-
ined, and they did not significantly differ from that ob-
served in normal skin. In this respect, pro-GelA activation
by MT1-MMP during rat skin wound healing differs from
that of pro-GelB by ST1, although both MMPs are pre-
dominantly found in the wound stroma. Another differ-
ence observed between GelA and GelB, is that the cells
expressing GelA transcripts are not found specifically at
the stromal-epithelial interface. The GelA transcripts are
in fact distributed throughout the wound stroma, both in
the granulation tissue and in the scar tissue. This observa-
tion suggests that GelA activated by MT1-MMP contrib-
utes to the remodeling processes implicated in the restora-
tion of connective tissue.
MT1-MMP as a Stromal Cell Surface Activator
of Pro-GelA
MT1-MMP is believed to correspond to a transmembrane
proteinase whose active site is orientated extracellularly
(Sato et al., 1994). Our finding that the MT1-MMP and
GelA genes are coexpressed in stromal cells, suggests that
MT1-MMP activates pro-GelA at the stromal cell surface
during rat skin wound healing. Consistent with this sugges-
tion, we observed that the induction of MT1-MMP by Con
A treatment in two different rat fibroblast cell lines, RAT1
and FR3T3, resulted in pro-GelA activation. We note that
similar observations have been made in human skin fibro-
blasts, where the processing of pro-GelA was coincident
with MT1-MMP expression induced by Con A treatment
(Atkinson et al., 1995). Furthermore, we have previously
shown that MT1-MMP and GelA transcripts were specifi-
cally detected in fibroblast-like cells of breast, colon, and
head and neck carcinomas (Okada et al., 1995a). More re-
cently, MT1-MMP transcripts and the MT1-MMP protein
Figure 5. MT1-MMP gene expression in rat fibroblasts and pro-
GelA activation in the presence of Con A. (A) Northern blot
analysis. 10 mg of total RNA obtained from RAT1 (lanes 1 and 2)
or FR3T3 (lanes 3 and 4) rat fibroblasts cultured in the absence
(lanes 1 and 3) or presence (lanes 2 and 4) of Con A (50 mg/ml)
were used in each lane. Blots were hybridized with 32P-labeled
rat MT1-MMP and GelA cDNA probes. Blots were reprobed
with the 36B4 cDNA used as a loading control (Masiakowski et al.,
1982). (B) Western blot analysis. Crude cell membrane extracts
corresponding to half a culture plate of subconfluent RAT1 (lanes
1 and 2) or FR3T3 (lanes 3 and 4) fibroblasts cultured in the
absence (lanes 1 and 3) or presence (lanes 2 and 4) of Con A (50
mg/ml) were analyzed. Proteins were detected using anti-rat
MT1-MMP mouse monoclonal antibody, 1MMP-1C1. (C) Gela-
tin zymography. 20 ml of medium conditioned by COS-1 cells
transiently transfected with pTL1GelA (lane 1), or pTL1GelA
and pTL1MT1-MMP (lane 2), and 20 ml of medium conditioned
by RAT1 (lanes 3 and 4) and FR3T3 (lanes 5 and 6) rat fibro-
blasts cultured in the absence (lanes 3 and 5) or presence (lanes 4
and 6) of Con A (50 mg/ml), were used.The Journal of Cell Biology, Volume 137, 1997 76
have been shown to be expressed by mesenchymal cells
during embryonic development (Kinoh et al., 1996). It re-
mains to be seen, however, whether GelA acts at the same
cell surface where it has been activated by MT1-MMP, or
on the surface of other cells, or maybe after binding to the
ECM. The possibility that GelA binds to cell surface sites
distinct from the extracellular domain of MT1-MMP is sup-
ported by a recent observation that active forms of GelA
bind to integrin avb3 on the surface of angiogenic blood
vessels (Brooks et al., 1996).
Further studies are required to precisely define the sites
where GelA is functionally active in remodeling tissues,
and to determine whether MT1-MMP and molecules such
as integrin avb3 cooperate in targeting active GelA to the
cell surface. The expression of integrin avb3 and/or mole-
cules with similar GelA-binding function at the stromal
cell surface during wound healing would be consistent
with our finding that the mature form of GelA is specifi-
cally found in the stroma. In this case, by activating pro-
GelA, MT1-MMP would contribute to the migration of
stromal cells and ECM remodeling implicated in the resto-
ration of the connective tissue during wound healing.
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